The S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) continued its solid form last week and climbed a further 105 points or 1.8% to 5879.6 points.
Not all shares on the benchmark index managed to follow it higher, though.
The worst performing shares on the index last week are listed below. Here’s why they underperformed:
The Star Entertainment Group Ltd (ASX: SGR) share price was the worst performer on the ASX 200 last week with a 7% decline. Although there was no news out of the company last week, investors have been selling off casino shares since late last year when their respective AGM updates underwhelmed. Star Entertainment’s shares were trading at a 52-week low on Friday despite the market’s positive move. One broker that sees this as an opportunity is Ord Minnett. Last week it revealed that it has retained its buy rating and $6.10 price target on the company’s shares.
The Estia Health Ltd (ASX: EHE) share price was the next worst performer with a 4% decline last week. The majority of this decline came on Friday when investors hit the sell button in hurry after the Royal Commission into Aged Care Quality and Safety got underway in Adelaide. This latest decline means the aged care provider’s shares have lost over 38% of their value since this time last year. I suspect its shares will remain under pressure until at least the release of the inquiry’s interim report in October.
The Lynas Corporation Ltd (ASX: LYC) share price was another poor performer last week with a decline of just under 4%. The rare earths company’s shares dropped lower despite there being no news out of it. Lynas shares have been sold off in recent months due to concerns over the future of its operations in Malaysia. Earlier this month Lynas appealed against the Malaysian government’s decision to mandate the removal of 450,000 metric tonnes of radioactive waste out of the country, but it remains unclear if it will succeed.
Need a lift after these declines? These top ASX shares have been tipped as potential market beaters in 2019.
Top 3 ASX Blue Chips To Buy For 2019
For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..
But knowing which blue chips to buy, and when, can be fraught with danger.
The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of “The Motley Fool’s Top 3 Blue Chip Stocks for 2019.“
Each one pays a fully franked dividend. The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.
Click here to claim your free report.
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool’s purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool’s free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2019